➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Express Scripts
McKesson
Dow
Boehringer Ingelheim

Last Updated: March 2, 2021

DrugPatentWatch Database Preview

TRASICOR Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Trasicor patents expire, and what generic alternatives are available?

Trasicor is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in TRASICOR is oxprenolol hydrochloride. There is one drug master file entry for this compound. Additional details are available on the oxprenolol hydrochloride profile page.

Summary for TRASICOR
Drug patent expirations by year for TRASICOR

US Patents and Regulatory Information for TRASICOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-001 Dec 28, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-004 Dec 28, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-002 Dec 28, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-003 Dec 28, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TRASICOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-002 Dec 28, 1983   Start Trial   Start Trial
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-003 Dec 28, 1983   Start Trial   Start Trial
Novartis TRASICOR oxprenolol hydrochloride CAPSULE;ORAL 018166-004 Dec 28, 1983   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Mallinckrodt
Dow
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.